Multiple Myeloma
Latest Articles
(PharmaTimes [UK]) Mar 17, 2017 - Janssen said it is extremely concerned that the National Institute for Health and Care Excellence (NICE) has not recommended Darzalex for treatment of relapsed and refractory multiple myeloma in adults in preliminary guidelines.
Read Article
(BioPharma Dive) Mar 12, 2017 - Karyopharm Therapeutics said March 10 it has responded to written notice from the Food and Drug Administration that clinical trials for the pharma’s oncology drug selinexor (KPT-330) have been placed on partial clinical hold.
Read Article
More Articles
March 08, 2017
March 03, 2017
March 03, 2017
March 03, 2017
March 02, 2017
February 28, 2017
February 24, 2017
February 24, 2017
View More
News Commentary
Editor Image
18 Apr, 2016 | by William McGivney, PhD
ICER: A Threat to OS in the US ...
View Comment
View More
OBR Green
There are no Multiple Myeloma OBR Green articles.
OBR Blog
This year's ASH Annual Meeting will be chock-full of interesting, informative, and clinically useful presentations,... Read more
November 22, 2016